Wybierz wielkość
| Rozmiar/SKU | Dostępność | Cena netto |
|---|---|---|
25 mg | Dostępne do wysyłki DZISIAJzKuehne + Nagel Sp. z o.o. | 758,00 zł |
Informacje o tej pozycji
Quality Segment
assay
≥97% (HPLC)
form
powder
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, protect from light
color
white
solubility
DMSO: 50 mg/mL
shipped in
ambient
storage temp.
2-8°C
SMILES string
O(c1cc(cc(c1)\C=C\c2ccc(cc2)OC(=O)C)OC(=O)C)C(=O)C
InChI
1S/C20H18O6/c1-13(21)24-18-8-6-16(7-9-18)4-5-17-10-19(25-14(2)22)12-20(11-17)26-15(3)23/h4-12H,1-3H3/b5-4+
InChI key
PDAYUJSOJIMKIS-SNAWJCMRSA-N
General description
Packaging
Preparation Note
Other Notes
Hsieh, T.C., et al. 2011. Int. J. Cancer129, 2732.
Legal Information
Disclaimer
1 of 1
Ta pozycja | |||
|---|---|---|---|
| description A cell-permeable triacetate resveratrol prodrug that is easily converted to resveratrol by esterase activity and exhibits similar bioactivity as resveratrol in cell cultures. | description A phenolic product found in both grape skins and wines. | description ≥98% (HPLC) | description BIO, CAS 667463-62-9, is a cell-permeable, highly potent, selective, reversible, and ATP-competitive inhibitor of GSK-3α/β (IC50 = 5 nM). Maintains self-renewal in human & mouse embryonic stem cells. |
| assay ≥97% (HPLC) | assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay ≥97% (HPLC) |
| form powder | form solid | form powder | form solid |
| manufacturer/tradename Calbiochem® | manufacturer/tradename Calbiochem® | manufacturer/tradename - | manufacturer/tradename Calbiochem® |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
| solubility DMSO: 50 mg/mL | solubility DMSO: 50 mg/mL | solubility DMSO: 20 mg/mL, clear | solubility DMSO: 5 mg/mL |
Klasa składowania
11 - Combustible Solids
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.



